Jeryl L. Hilleman has not been actively trading shares of NovoCure during the last quarter. Most recently, Jeryl L. Hilleman sold 407 shares of the business's stock in a transaction on Friday, June 10th. The shares were sold at an average price of $69.61, for a transaction totalling $28,331.27. Following the completion of the sale, the director now directly owns 2,537 shares of the company's stock, valued at $176,600.57. Learn More on Jeryl L. Hilleman's trading history.